Lemme NJ, Li NY, DeFroda SF, Kleiner J, Owens BD. Epidemiology of Achilles tendon ruptures in the United States: athletic and nonathletic injuries from 2012 to 2016. Orthop J Sports Med. 2018;6:2325967118808238.
Article PubMed PubMed Central Google Scholar
Hsu D, Anand P, Mabrouk A, Chang KV. Biceps tendon rupture. StatPearls. Treasure Island: StatPearls Publishing; 2023.
Tempelhof S, Rupp S, Seil R. Age-related prevalence of rotator cuff tears in asymptomatic shoulders. J Shoulder Elbow Surg. 1999;8:296–9.
Article CAS PubMed Google Scholar
Minagawa H, Yamamoto N, Abe H, Fukuda M, Seki N, Kikuchi K, et al. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: from mass-screening in one village. J Orthop. 2013;10:8–12.
Article PubMed PubMed Central Google Scholar
Xergia SA, Tsarbou C, Liveris NI, Hadjithoma M, Tzanetakou IP. Risk factors for Achilles tendon rupture: an updated systematic review. Phys Sportsmed. 2023;51:506–51. https://doi.org/10.1080/00913847.2022.2085505.
Gaida JE, Ashe MC, Bass SL, Cook JL. Is adiposity an under-recognized risk factor for tendinopathy? A systematic review. Arthritis Rheum. 2009;61:840–9.
Noback PC, Jang ES, Cuellar DO, Seetharaman M, Malagoli E, Greisberg JK, et al. Risk factors for achilles tendon rupture: a matched case control study. Injury. 2017;48:2342–7.
Eliasson P, Dietrich-Zagonel F, Lundin AC, Aspenberg P, Wolk A, Michaelsson K. Statin treatment increases the clinical risk of tendinopathy through matrix metalloproteinase release—a cohort study design combined with an experimental study. Sci Rep. 2019;9:17958.
Article PubMed PubMed Central Google Scholar
Abboud JA, Kim JS. The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res. 2010;468:1493–7.
Kraemer R, Wuerfel W, Lorenzen J, Busche M, Vogt PM, Knobloch K. Analysis of hereditary and medical risk factors in Achilles tendinopathy and Achilles tendon ruptures: a matched pair analysis. Arch Orthop Trauma Surg. 2012;132:847–53.
Yang Y, Lu H, Qu J. Tendon pathology in hypercholesterolaemia patients: epidemiology, pathogenesis and management. J Orthop Translat. 2019;16:14–22.
Lewis T, Cook J. Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature. J Athl Train. 2014;49:422–7.
Article PubMed PubMed Central Google Scholar
Scott A, Backman LJ, Speed C. Tendinopathy: update on pathophysiology. J Orthop Sports Phys Ther. 2015;45:833–41.
Wang W-T, Huang S-W, Liou T-H, Lin H-W. Patients with rheumatoid arthritis were associated with a risk of rotator cuff diseases. J Clin Med. 2019;8:129.
Article CAS PubMed PubMed Central Google Scholar
Otter S, Payne C, Jones AM, Webborn N, Watt P. Differences in Achilles tendon stiffness in people with gout: a pilot study. BMC Musculoskelet Disord. 2020;21:658.
Article PubMed PubMed Central Google Scholar
Lin CY, Huang SC, Tzou SJ, Yin CH, Chen JS, Chen YS, et al. A positive correlation between steroid injections and cuff tendon tears: a cohort study using a clinical database. Int J Environ Res Public Health. 2022;19:4520.
Article CAS PubMed PubMed Central Google Scholar
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:e285–350.
Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67:2395–410.
Article CAS PubMed Google Scholar
Fonarow GC, Kosiborod MN, Rane PB, Nunna S, Villa G, Habib M, et al. Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease. Clin Cardiol. 2021;44:1457–66.
Article PubMed PubMed Central Google Scholar
Klimchak AC, Patel MY, Iorga SR, Kulkarni N, Wong ND. Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States. Am J Prevent Cardiol. 2020;1:100010.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e563–95.
PubMed PubMed Central Google Scholar
Pullatt RC, Gadarla MR, Karas RH, Alsheikh-Ali AA, Thompson PD. Tendon rupture associated with simvastatin/ezetimibe therapy. Am J Cardiol. 2007;100:152–3.
Article CAS PubMed Google Scholar
Gowdar SD, Thompson PD. Multiple tendon ruptures associated with statin therapy. J Clin Lipidol. 2020;14:189–91.
Thompson PD, Arora S, Duvall WL. Tendonopathy due to simvastatin and ezetimibe, amyloidosis or both? Am J Cardiol. 2020;130:165.
Article CAS PubMed Google Scholar
Hoffman KB, Kraus C, Dimbil M, Golomb BA. A survey of the FDA’s AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One. 2012;7:e42866.
Article CAS PubMed PubMed Central Google Scholar
Pfizer. LIPITOR® (atorvastatin calcium) [package insert]. New York, NY. 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020702s073lbl.pdf. Accessed Sep 9, 2022.
Bristol Myers Squibb. PRAVACHOL® (pravastatin sodium) [package insert]. Princeton, NJ. 2020. https://packageinserts.bms.com/pi/pi_pravachol.pdf. Accessed Sep 9, 2022.
Teichtahl AJ, Brady SR, Urquhart DM, Wluka AE, Wang Y, Shaw JE, et al. Statins and tendinopathy: a systematic review. Med J Aust. 2016;204:115-21.e1.
Contractor T, Beri A, Gardiner JC, Tang X, Dwamena FC. Is statin use associated with tendon rupture? A population-based retrospective cohort analysis. Am J Ther. 2015;22:377–81.
Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Role of bempedoic acid in clinical practice. Cardiovasc Drugs Ther. 2021;35:853–64.
Article CAS PubMed PubMed Central Google Scholar
Esperion Therapeutics Inc. NEXLETOL® (bempedoic acid) prescribing information. 2024. https://pi.esperion.com/nexletol/nexletol-pi.pdf. Accessed Apr 18, 2024.
Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, et al. Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR Wisdom randomized clinical trial. JAMA. 2019;322:1780–8.
Article CAS PubMed PubMed Central Google Scholar
Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, et al. Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N Engl J Med. 2019;380:1022–32.
Article CAS PubMed Google Scholar
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388:1353–64.
Bays HE, Bloedon LT, Lin G, Powell HA, Louie MJ, Nicholls SJ, et al. Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance. J Clin Lipidol. 2023:S1933–2874(23)00313–6
Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X. Relative and absolute risk of tendon rupture with fluoroquinolone and concomitant fluoroquinolone/corticosteroid therapy: populati
Comments (0)